Clinical Presentation of Testosterone Deficiency

Course Overview

Clinical presentation is the front end of diagnosis. In practice, some men are labeled hypogonadal too quickly because they report nonspecific symptoms such as fatigue, low motivation, or poor concentration, even though these complaints are common across many other conditions. Others are underrecognized because they do not present seeking evaluation for testosterone deficiency. Instead, they enter through infertility, reduced morning erections, diminished libido, unexplained anemia, osteopenia, or physical findings that more clearly suggest androgen deficiency than their initial complaint. [1–4]

This course focuses on diagnostic discipline before treatment is considered. Emphasis is placed on the sexual symptom cluster, since it remains the most clinically useful adult feature when present together with laboratory confirmation. Many factors listed in the course can influence interpretation. Our goal is to recognize the syndrome accurately, classify it appropriately, and avoid both overdiagnosis and underrecognition. [1-6]

Learning Objectives

After completing this course, clinicians should be able to:

➀ Define testosterone deficiency as a clinical syndrome that requires both compatible symptoms or signs and consistently low serum testosterone.

➁ Identify the most diagnostically useful adult symptom pattern, especially the sexual cluster of low libido, reduced morning erections, and erectile dysfunction.

➂ Distinguish common but less specific symptoms, such as fatigue, low mood, poor concentration, and reduced performance, from features that more strongly support androgen deficiency.

➃ Recognize physical, reproductive, and age-dependent manifestations of testosterone deficiency, including infertility, testicular findings, anemia, osteopenia, and delayed pubertal development.

➄ Differentiate classical organic hypogonadism from functional hypogonadism and explain why similar outward presentations may reflect very different underlying biology.

➅ Perform a focused history and physical examination that identifies symptom pattern, fertility goals, risk factors, medication contributors, sleep disruption, and clues to pituitary or testicular disease.

➆ Avoid treating nonspecific symptoms or isolated laboratory values as proof of testosterone deficiency in the absence of a coherent clinical syndrome.

Course Topics

The following topics will be covered in the course text, video, diagrams or downloadable documents:

➀ Definition And Clinical Framing

➁ Why Clinical Presentation Matters More Than Numbers Alone

➂ The Sexual Symptom Cluster

➃ Common But Less Specific Symptoms

➄ Physical Signs And Downstream Manifestations

➅ Fertility As A Presentation Pathway

➆ Phenotype By Age Of Onset

➇ Organic Versus Functional Hypogonadism

➈ Focused Clinical History

⑩ Focused Physical Examination

⑪ What Not To Overcall

⑫ Society-Based Consensus And Practical Take-Home Points

Video Lesson Takeaways

◉ Testosterone deficiency is a clinical syndrome, not a laboratory label.

◉ Diagnosis requires both compatible symptoms or signs and consistently low serum testosterone measured under appropriate conditions.

◉ In adult men, the most diagnostically useful presentation is sexual, especially low libido, loss of morning erections, and erectile dysfunction.

◉ Fatigue, low mood, poor concentration, and reduced physical performance are common, but they are far less specific.

◉ Some men present through infertility, anemia, bone loss, or testicular findings rather than through a direct sexual complaint.

◉ Similar presentations can arise from very different biology, including structural hypogonadism and potentially reversible functional suppression.

◉ Focused history matters because obesity, diabetes, sleep apnea, opioids, glucocorticoids, anabolic steroids, chronic illness, and circadian disruption can all affect presentation and interpretation.

◉ Clinicians must avoid treating numbers in isolation and instead learn to recognize phenotype, cause, and context before initiating androgen therapy.

➀ Definition And Clinical Framing

Testosterone deficiency, or male hypogonadism, is a clinical syndrome of androgen deficiency arising from dysfunction at the testicular level, the hypothalamic-pituitary level, or both. Symptoms come first. The laboratory result then confirms, refines, or challenges the impression. A man can have symptoms without testosterone deficiency, and he can have a low testosterone value without a clinically meaningful phenotype. Androgen therapy affects multiple physiologic systems, including cardiovascular, hematologic, reproductive, and metabolic health [1-4].

➁ Why Clinical Presentation Matters More Than Numbers Alone

Clinical interpretation of testosterone values depends on context. The same laboratory result can carry very different meanings based on many factors. A borderline value in a man with low libido, loss of morning erections, infertility, and testicular findings does not carry the same diagnostic weight as a similar value in a sleep-deprived, obese man with vague fatigue and no clear sexual or reproductive symptoms. In practice, many patients presenting for evaluation have already received a prior diagnosis and are seeking long-term management rather than initial identification of the syndrome.[1-4]

➂ The Sexual Symptom Cluster

In adult men, the most diagnostically useful presentation remains sexual. Low libido, reduced morning erections, and erectile dysfunction carry more diagnostic weight than generalized low energy, poor concentration, or reduced drive, especially when they move together and fit the broader clinical picture. This is one reason multiple guidelines and reviews place sexual symptoms near the center of diagnostic reasoning and treatment benefit. [1-4]

That does not mean sexual symptoms are perfectly specific. Erectile dysfunction may be multifactorial. When low desire, reduced spontaneous or morning erections, and erectile dysfunction occur together, the probability of clinically meaningful androgen deficiency increases substantially. [1-4]

➃ Common But Less Specific Symptoms

Regularly encountered but less specific symptoms include:

Fatigue
Low energy
Reduced endurance
Low mood
Irritability
Reduced motivation
Poor concentration
Reduced sense of well-being

These symptoms all deserve evaluation. They do not, by themselves, establish testosterone deficiency. These complaints are common across obesity, sleep restriction, depression, chronic pain, diabetes, medication effects, overwork, circadian disruption, and general physiologic strain. They may coexist with low testosterone, but they are too nonspecific to establish a defined endocrine syndrome on their own. That distinction is one of the most important forms of diagnostic restraint in androgen medicine.

➄ Physical Signs And Downstream Manifestations

Physical and downstream clues that deserve particular attention include:

Reduced testicular volume or soft testes
Decreased facial or body hair in more severe deficiency
Reduced lean muscle mass and strength
Increased visceral or central adiposity
Gynecomastia or breast tenderness
Osteopenia or osteoporosis
Fragility fractures or height loss
Anemia without a better explanation
Hot flashes or sweats in more severe deficiency

These findings add weight to the diagnosis and broaden the syndrome beyond subjective complaint. The Endocrine Society guideline explicitly includes many of these signs and manifestations among features that should raise suspicion for androgen deficiency. [1-3]

Some of these findings carry extra diagnostic value because they reflect downstream physiologic consequences rather than mood-based descriptions. Bone loss, fragility fractures, and unexplained anemia should not be treated as background details in a man with possible hypogonadism. They often point toward more chronic or more biologically meaningful androgen deficiency. [1-3]

➅ Fertility As A Presentation Pathway

Some men do not present through sexual complaints at all. They present because they cannot conceive. This is one of the most important, and most commonly mishandled, entry points into testosterone deficiency. Infertility, oligospermia, azoospermia, abnormal semen parameters, and small testes may be the first clue that the hypothalamic-pituitary-testicular axis is not functioning normally. Reproductive health evaluation before testosterone treatment is explicitly emphasized in guideline-based care. [1-2]

Fertility changes the meaning of the presentation immediately. A clinician who reflexively hears “low testosterone” and thinks “testosterone replacement” has already skipped an essential diagnostic step. Even before management is discussed, reproductive presentation should sharpen attention to longstanding axis dysfunction, primary testicular disease, central causes, prior anabolic steroid exposure, and the difference between diagnostic clarification and treatment momentum.

➆ Phenotype By Age Of Onset

Age of onset changes phenotype. Congenital conditions such as Kallmann syndrome and Klinefelter syndrome represent classical causes of longstanding hypogonadism that may present during puberty or early adulthood. Prepubertal or pubertal-onset hypogonadism may present with delayed puberty, under-virilization, sparse facial or body hair, small testes, reduced muscle development, and eunuchoidal body proportions. Adult-onset hypogonadism presents differently. Instead of absent development, the clinician sees loss or decline. [1-3]

That distinction matters because similar laboratory values can carry very different clinical meaning depending on developmental history. A man who never fully virilized or who had abnormal pubertal progression should immediately raise concern for longstanding central pathology. A middle-aged man with recent symptom onset and obesity-related comorbidity belongs to a different diagnostic frame. Developmental timing can help determine what kind of disease the clinician is actually looking at.

➇ Organic Versus Functional Hypogonadism

One important distinction in modern androgen medicine is the difference between classical organic hypogonadism and functional hypogonadism. Organic hypogonadism reflects structural or irreversible pathology affecting the testes, hypothalamus, or pituitary. Functional hypogonadism reflects potentially reversible suppression of the axis related to obesity, systemic disease, medication exposure, undernutrition, sleep disruption, or other physiologic stressors. [1,5-6]

This distinction can change what further evaluation should look like, how strongly reversibility should be pursued, and how carefully the diagnosis should be framed before treatment is started. Organic hypogonadism should raise concern for entities such as pituitary or hypothalamic disease, congenital GnRH deficiency states, Klinefelter syndrome, prior orchitis, torsion, testicular injury, chemotherapy, radiation, or other gonadal pathology. Functional hypogonadism is commonly seen with obesity, type 2 diabetes, obstructive sleep apnea, chronic systemic illness, opioid or glucocorticoid exposure, severe stress, marked caloric deficit, or prior anabolic steroid exposure, which may lead to anabolic steroid–induced hypogonadism (ASIH).

➈ Focused Clinical History

A strong history clarifies pattern, time course, severity, reversibility, and competing explanations. Loss of libido after years of normal function carries a different differential than incomplete pubertal development. New erectile dysfunction with preserved desire is not the same as parallel loss of desire and spontaneous erections. Fertility goals, fracture history, vasomotor symptoms, changes in muscle and fat distribution, and the timing of symptoms relative to weight gain, shift work, opioid use, steroid exposure, or major illness can all reshape the diagnostic impression before the laboratory workup is even reviewed. [1,5-6]

Risk-factor history is equally important. Obesity, diabetes, sleep apnea, chronic kidney or liver disease, HIV, pituitary symptoms such as headache or visual change, prior orchitis or torsion, chemotherapy, radiation, anabolic steroid exposure, glucocorticoids, and opioids all alter interpretation. Circadian disruption from shift work, night schedules, or irregular sleep patterns may also contribute to symptomatic testosterone suppression and should be specifically assessed. [1,5-6]

Useful history domains include:

Sexual function pattern, including libido, morning erections, erectile change, and fertility goals
Timing of symptoms in relation to illness, weight change, sleep disruption, medication exposure, or anabolic steroid use
Pubertal development and developmental clues suggesting longstanding disease
Pituitary or central symptoms such as headache, visual change, anosmia, or prior brain injury
Chronic disease burden, including obesity, diabetes, sleep apnea, kidney disease, liver disease, and inflammatory illness
Drug exposures such as opioids, glucocorticoids, chemotherapy, radiation, and exogenous androgens [1,5-6]
A focused history is not a formality. In many patients, it is the highest-yield diagnostic tool in the visit

➉ Focused Physical Examination

Physical examination can help uncover findings that shift the diagnostic story. Central adiposity and blood pressure may strengthen the case for functional suppression and cardiometabolic strain. Hair distribution and secondary sexual characteristics may raise concern for longstanding androgen deficiency. Gynecomastia, testicular size, and consistency may shift the clinician toward primary testicular or reproductive pathology. Skeletal clues such as height loss or kyphosis can point toward more chronic physiologic consequences. Examination should also remain attentive to testicular masses or asymmetry that could indicate underlying malignancy requiring urgent urologic evaluation. [1-3]

⑪ What Not To Overcall

One of the most valuable skills in this field is knowing what not to call testosterone deficiency. Low energy alone is not testosterone deficiency. Poor concentration alone is not testosterone deficiency. These complaints deserve attention, but they do not establish the syndrome by themselves. [1-4]

Likewise, an isolated testosterone value should not function as diagnostic closure when the phenotype is weak, the symptoms are nonspecific, or reversible suppressive factors are obvious. Overcalling usually happens when clinicians collapse multiple diagnostic steps into one. The antidote is disciplined weighting of symptoms, signs, cause, and context before treatment is even discussed.

Regularly overcalled scenarios include:

Fatigue without persuasive sexual symptoms
Obesity-related low testosterone with no attempt to interpret reversibility
Poor sleep or shift work with weak endocrine symptoms
Depression, chronic pain, or medication burden being relabeled as primary androgen deficiency
Isolated laboratory values being treated as more meaningful than the clinical picture

COURSE SUMMARY

Clinical Presentation of Testosterone Deficiency teaches that diagnosis begins with clinical presentation, not with treatment interest and not with an isolated laboratory value. Adult men with low libido, reduced morning erections, and erectile dysfunction carry the most diagnostically useful symptom pattern, especially when that cluster is supported by reproductive clues, physical findings, or downstream manifestations such as anemia or bone loss. The practical result is better diagnostic discipline, less overcalling, and more defensible androgen medicine.

REFERENCES

Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. doi:10.1210/jc.2018-00229
Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. doi:10.1016/j.juro.2018.03.115
American College of Physicians Clinical Guidelines Committee. Testosterone treatment in adult men with age-related low testosterone: a clinical guideline. Ann Intern Med. 2020;172(2):126-133. doi:10.7326/M19-0882
European Association of Urology. EAU Guidelines on Sexual and Reproductive Health: Male Hypogonadism. Updated edition.
Grossmann M, Matsumoto AM. The evaluation and management of men ≥50 years with low serum testosterone concentration. J Clin Endocrinol Metab. 2023;108(9):e871-e890.
Munro V, Grossmann M. Secondary hypogonadism and effects of testosterone treatment: newer concepts and controversies. J Clin Endocrinol Metab. 2025.
Nieschlag E, Behre HM, Nieschlag S. Andrology: Male Reproductive Health and Dysfunction. Standard reference text on androgen deficiency phenotypes and developmental presentation.

Clinical Presentation of Testosterone Deficiency

Course Overview

Learning Objectives

Course Topics

002 Clinical Presentation of Testosterone Deficiency

Video Lesson Takeaways

➀ Definition And Clinical Framing

➁ Why Clinical Presentation Matters More Than Numbers Alone

➂ The Sexual Symptom Cluster

➃ Common But Less Specific Symptoms

➄ Physical Signs And Downstream Manifestations

➅ Fertility As A Presentation Pathway

➆ Phenotype By Age Of Onset

➇ Organic Versus Functional Hypogonadism

➈ Focused Clinical History

➉ Focused Physical Examination

⑪ What Not To Overcall

⑫ Society-Based Consensus And Practical Take-Home Points

Recommended Grand Rounds Case Reviews